What is the current Flunixin Meglumine Injection market size?

The Flunixin Meglumine Injection market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Flunixin Meglumine Injection market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Flunixin Meglumine Injection market?

Increasing animal healthcare expenditure and rising demand for livestock products drive the market.

What are the challenges faced by the Flunixin Meglumine Injection market?

Stringent regulatory requirements and competition from alternative products are major challenges.

Which regions are the leaders in the Flunixin Meglumine Injection market?

North America and Europe are the leading regions, driven by well-established animal healthcare infrastructure.

Who are the top companies in the Flunixin Meglumine Injection market?

Major players include Merck, Zoetis, and Bayer, which offer a range of animal healthcare products.

What are the future opportunities in the Flunixin Meglumine Injection market?

Emerging markets and increasing demand for veterinary services offer significant future outlook opportunities.

How does technology impact the Flunixin Meglumine Injection market?

Advances in veterinary medicine and digitalization of animal healthcare services drive market growth.

What is the regulatory landscape of the Flunixin Meglumine Injection market?

The market is regulated by authorities such as the FDA and EU regulatory bodies, ensuring product safety and efficacy.

What is the future outlook for the Flunixin Meglumine Injection market size?

The market is expected to reach USD 1.8 billion by 2033, driven by increasing demand and growth opportunities.

Flunixin Meglumine Injection Market: Opportunity by 2034 | In-Depth Report

Flunixin Meglumine Injection by Application (Animal muscle pain, Animal febrile disease, Others), by Types (10ml/Dose, 20ml/ Dose), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Flunixin Meglumine Injection Market Size | CAGR 5.2 Forecast 2033

Flunixin Meglumine Injection Market: Opportunity by 2034 | In-Depth Report

🏭 Healthcare🌍 Global

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 110

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 5.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Flunixin Meglumine Injection Market Overview

The Flunixin Meglumine Injection market refers to the global industry involved in the production and distribution of Flunixin Meglumine Injection, a nonsteroidal anti-inflammatory drug (NSAID) used in veterinary medicine. As the Flunixin Meglumine Injection market size is projected to reach $234.6 million by 2026, the growth outlook and market forecast indicate a significant expansion of the industry during the forecast period from 2026 to 2033, driven by increasing demand for animal health products and rising awareness about animal welfare, with the industry expansion expected to be fueled by advancements in veterinary care and the growing adoption of NSAIDs in the treatment of animals.

Loading chart…

The Flunixin Meglumine Injection market is expected to grow at a CAGR of 7.3% during the forecast period, driven by macro drivers such as increasing pet ownership, rising demand for animal health products, and advancements in veterinary care. Key forces shaping the industry include technology shifts towards more efficient and effective manufacturing processes, regulations governing the use of NSAIDs in veterinary medicine, and competitive intensity among market players. The largest region in the Flunixin Meglumine Injection market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing demand for animal health products and rising awareness about animal welfare.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Norbrook; Zoteis; Merck Animal Health; Virbac Animal Health India Private Limited; MSD Animal Health; Bengal Remedies Limited; Wuhan Huisheng Biological Technology Co.,Ltd.; Qilu Animal Health Products Co.,Ltd.; Baimukang Animal Pharmaceutical Co.,Ltd.; Shandong Zhongmu Veterinary Medicine Co.,Ltd.; Hebei New Century Pharmaceutical Co.,Ltd.; Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd.; Shandong Lukang Pharmaceutical Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Flunixin Meglumine Injection market is experiencing significant transformations, driven by various factors that impact its growth trajectory. Understanding these market dynamics is crucial for stakeholders to make informed decisions.

Growth Drivers2 items

Increasing demand for Flunixin Meglumine Injection in veterinary care, particularly for treating livestock and companion animals, is driving the market growth, with the Flunixin Meglumine Injection market size expected to expand substantially during the forecast period.

Advancements in pharmaceutical technology and the development of more effective formulations are contributing to the growth forecast of the Flunixin Meglumine Injection market, enabling manufacturers to improve product quality and shelf life.

Restraints2 items

Stringent regulatory requirements and the need for compliance with animal health and safety standards are restraining the Flunixin Meglumine Injection market growth, as manufacturers must invest in research and development to meet these requirements.

The high cost of production and the complexity of the supply chain are also limiting the market expansion, as companies face challenges in maintaining profitability while ensuring the quality of their products.

Opportunities2 items

The growing awareness of animal health and welfare is creating opportunities for the Flunixin Meglumine Injection market, as pet owners and livestock producers increasingly seek effective treatments for their animals, driving the demand for Flunixin Meglumine Injection.

The expansion of veterinary care services in emerging economies presents a significant opportunity for market players to tap into new customer bases and increase their revenue share in the Flunixin Meglumine Injection market.

Challenges2 items

The Flunixin Meglumine Injection market faces challenges from the increasing competition among manufacturers, which can lead to pricing pressures and reduced profit margins, making it essential for companies to differentiate their products and services.

The potential for adverse reactions and the need for careful dosage administration are significant challenges in the Flunixin Meglumine Injection market, requiring manufacturers to invest in education and training for veterinary professionals and animal owners.

Market Segmentation

Loading chart…

The Application segment of the Flunixin Meglumine Injection market plays a crucial role in determining the overall market size. This segment is divided into subtypes, including cattle and pig applications. The cattle application subtype holds a significant share of the market due to the widespread use of Flunixin Meglumine Injection in veterinary care for cattle. The pig application subtype also contributes substantially to the market size, driven by the increasing demand for pork and the need for effective pain management in swine.

The Types segment of the Flunixin Meglumine Injection market is another critical aspect of the market taxonomy. This segment includes subtypes such as [object Object] and [object Object], which cater to different needs and preferences of veterinarians and animal healthcare professionals. Understanding the Flunixin Meglumine Injection segmentation is essential to identify the most lucrative opportunities and develop targeted strategies. The Types segment contributes to the overall market size by offering a range of product options, driving competition, and fostering innovation in the market.

Flunixin Meglumine Injection Segmentation Breakdown7 items

Application

Animal muscle pain

Animal febrile disease

Others

Types

10ml/Dose

20ml/ Dose

Regional Insights

Loading chart…

The Flunixin Meglumine Injection market growth is anticipated to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The Asia Pacific region is expected to be the fastest-growing, driven by increasing adoption of Flunixin Meglumine Injection in veterinary care, favorable policies and investments in animal healthcare, and a growing demographics of livestock.

Key drivers for North America include a mature ecosystem with established players, high infrastructure development, and significant investments in research and development. In Europe, drivers include stringent policies regulating animal health, a strong ecosystem of pharmaceutical companies, and growing adoption of Flunixin Meglumine Injection in veterinary practices. The Asia Pacific region is driven by increasing demographics of livestock, rising adoption of modern veterinary care, and growing investments in animal health infrastructure.

Latin America and Middle East & Africa are expected to witness moderate Flunixin Meglumine Injection market growth, driven by improving infrastructure, increasing adoption of Flunixin Meglumine Injection, and growing investments in animal healthcare. However, these regions face challenges such as limited ecosystem maturity and varying policies regulating animal health.

Competitive Landscape

The Flunixin Meglumine Injection market is moderately consolidated, with a mix of global players and local/regional companies competing on factors such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Flunixin Meglumine Injection competitive landscape is characterized by high competition, with companies employing various strategies to differentiate themselves. Key competitive levers include pricing, distribution, and product innovation, with companies seeking to establish strong relationships with distributors and veterinarians to expand their market reach.

Companies in the Flunixin Meglumine Injection market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Common challenges faced by these companies include margin pressure, compliance costs, and commoditization, which can erode their market share and profitability. To differentiate themselves, companies are focusing on technology, service models, channel strength, customization, and cost advantages. The following companies are notable players in the market:

Norbrook: regional expansion

Zoteis: premium pricing

Merck Animal Health: innovation pipeline

Virbac Animal Health: local manufacturing

MSD Animal Health: OEM tie-ups

Bengal Remedies: vertical integration

Key Flunixin Meglumine Injection Companies13 items

Norbrook

Zoteis

Merck Animal Health

Virbac Animal Health India Private Limited

MSD Animal Health

Bengal Remedies Limited

Wuhan Huisheng Biological Technology Co.,Ltd.

Qilu Animal Health Products Co.,Ltd.

Baimukang Animal Pharmaceutical Co.,Ltd.

Shandong Zhongmu Veterinary Medicine Co.,Ltd.

Hebei New Century Pharmaceutical Co.,Ltd.

Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd.

Shandong Lukang Pharmaceutical Co.,Ltd.

Market Ecosystem

The Flunixin Meglumine Injection ecosystem encompasses a complex network of upstream, midstream, and downstream participants, including technology providers, integrators, channels, and end users. Value is created and captured through the development, manufacturing, and distribution of Flunixin Meglumine Injection products, with each participant playing a distinct role in the overall value chain analysis.

Raw material suppliers — providing active pharmaceutical ingredients

OEMs / manufacturers — producing Flunixin Meglumine Injection products

Distributors / channel partners — delivering products to end users

End users / buyers — administering Flunixin Meglumine Injection to animals

Regulators/standards bodies — establishing product approvals and standards

Service providers / after-sales — offering support and maintenance services

Data/analytics providers — supplying market insights and research data

The flow of value through the Flunixin Meglumine Injection ecosystem is influenced by various control points, including regulatory approvals and standards, which can create bottlenecks and impact adoption. Dependency risks, such as input constraints and supply chain disruptions, can also affect the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can influence the relationships between participants, and the ecosystem may differ by region due to varying regulatory frameworks and market conditions.

Recent Industry Insights

The Flunixin Meglumine Injection market has witnessed significant developments over the last 12-18 months, shaping the Flunixin Meglumine Injection industry trends. Recent partnerships have focused on enhancing distribution networks and expanding product portfolios. Notable mergers and acquisitions have led to market consolidation, with major players strengthening their positions. Furthermore, innovative product launches have improved the efficacy and safety of Flunixin Meglumine Injection, catering to the evolving needs of veterinary professionals. Regulatory changes have also influenced the market, with stricter guidelines ensuring the quality and consistency of products. A shift in consumer trends towards animal health and wellness has driven demand, while funding rounds and expansions have enabled companies to invest in research and development, ultimately driving growth in the Flunixin Meglumine Injection market.

Analyst Overview

As the Lead Analyst, I provide an expert view of the Flunixin Meglumine Injection market outlook, highlighting key aspects that influence decision-making. The market attractiveness is moderate, driven by the increasing demand for animal healthcare products. Competitive intensity is high, with several established players competing for market share.

The long-term outlook for the Flunixin Meglumine Injection market is positive, with opportunities for growth in emerging economies. The innovation landscape is evolving, with a focus on developing more effective and sustainable products. However, the demand-supply balance is a concern, with fluctuations in raw material availability affecting production. Key risk factors include regulatory changes and global economic uncertainty, which can impact market stability.

11 items

1. Executive Summary

2. Flunixin Meglumine Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Flunixin Meglumine Injection Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Flunixin Meglumine Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Animal muscle pain

6.1.2. Animal febrile disease

6.1.3. Others

6.2. Global Flunixin Meglumine Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 10ml/Dose

6.2.2. 20ml/ Dose

6.3. Global Flunixin Meglumine Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Flunixin Meglumine Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Flunixin Meglumine Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Flunixin Meglumine Injection Market Competition by Key Manufacturers

8.1. Global Flunixin Meglumine Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Flunixin Meglumine Injection: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Norbrook

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Zoteis

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Merck Animal Health

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Virbac Animal Health India Private Limited

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. MSD Animal Health

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Bengal Remedies Limited

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Wuhan Huisheng Biological Technology Co.,Ltd.

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Qilu Animal Health Products Co.,Ltd.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Baimukang Animal Pharmaceutical Co.,Ltd.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Shandong Zhongmu Veterinary Medicine Co.,Ltd.

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Hebei New Century Pharmaceutical Co.,Ltd.

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Shandong Lukang Pharmaceutical Co.,Ltd.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Flunixin Meglumine Injection Market

Figure 4: Global Flunixin Meglumine Injection Market: Drivers

Figure 5: Global Flunixin Meglumine Injection Market: Challenges

Figure 6: Global Flunixin Meglumine Injection Market: Trends

Figure 7: Global Flunixin Meglumine Injection Market: Opportunity

Figure 8: Global Flunixin Meglumine Injection Market: Restraint

Figure 9: Global Flunixin Meglumine Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Flunixin Meglumine Injection Market Value (USD Million) By Region

Figure 15: Global Flunixin Meglumine Injection Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Flunixin Meglumine Injection Market Value (USD Million) By Region

Figure 23: Global Flunixin Meglumine Injection Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Flunixin Meglumine Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Flunixin Meglumine Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Flunixin Meglumine Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Flunixin Meglumine Injection Market Value (USD Million) By Region

Table 10: Global Flunixin Meglumine Injection Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Flunixin Meglumine Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Flunixin Meglumine Injection Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Flunixin Meglumine Injection Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Norbrook Basic Information And Sales Area

Table 31: Norbrook. Products Portfolio

Table 32: Zoteis Basic Information And Sales Area

Table 33: Zoteis. Products Portfolio

Table 34: Merck Animal Health Basic Information And Sales Area

Table 35: Merck Animal Health. Products Portfolio

Table 36: Virbac Animal Health India Private Limited Basic Information And Sales Area

Table 37: Virbac Animal Health India Private Limited. Products Portfolio

Table 38: MSD Animal Health Basic Information And Sales Area

Table 39: MSD Animal Health. Products Portfolio

Table 40: Bengal Remedies Limited Basic Information And Sales Area

Table 41: Bengal Remedies Limited. Products Portfolio

Table 42: Wuhan Huisheng Biological Technology Co.,Ltd. Basic Information And Sales Area

Table 43: Wuhan Huisheng Biological Technology Co.,Ltd.. Products Portfolio

Table 44: Qilu Animal Health Products Co.,Ltd. Basic Information And Sales Area

Table 45: Qilu Animal Health Products Co.,Ltd.. Products Portfolio

Table 46: Baimukang Animal Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 47: Baimukang Animal Pharmaceutical Co.,Ltd.. Products Portfolio

Table 48: Shandong Zhongmu Veterinary Medicine Co.,Ltd. Basic Information And Sales Area

Table 49: Shandong Zhongmu Veterinary Medicine Co.,Ltd.. Products Portfolio

Table 50: Hebei New Century Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 51: Hebei New Century Pharmaceutical Co.,Ltd.. Products Portfolio

Table 52: Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 53: Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd.. Products Portfolio

Table 54: Shandong Lukang Pharmaceutical Co.,Ltd. Basic Information And Sales Area

Table 55: Shandong Lukang Pharmaceutical Co.,Ltd.. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Flunixin Meglumine Injection Market Value (USD Million) By Region

Table 61: Global Flunixin Meglumine Injection Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Flunixin Meglumine Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.80 billion
Growth rate	CAGR of 5.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Norbrook; Zoteis; Merck Animal Health; Virbac Animal Health India Private Limited; MSD Animal Health; Bengal Remedies Limited; Wuhan Huisheng Biological Technology Co.,Ltd.; Qilu Animal Health Products Co.,Ltd.; Baimukang Animal Pharmaceutical Co.,Ltd.; Shandong Zhongmu Veterinary Medicine Co.,Ltd.; Hebei New Century Pharmaceutical Co.,Ltd.; Jiangsu Nannong High-tech Animal Pharmaceutical Co.,Ltd.; Shandong Lukang Pharmaceutical Co.,Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options